TARZIA, GIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 27.524
EU - Europa 16.637
AS - Asia 9.731
SA - Sud America 589
AF - Africa 103
Continente sconosciuto - Info sul continente non disponibili 83
OC - Oceania 35
AN - Antartide 1
Totale 54.703
Nazione #
US - Stati Uniti d'America 27.301
GB - Regno Unito 6.183
CN - Cina 5.556
UA - Ucraina 2.758
SG - Singapore 2.182
IT - Italia 1.739
SE - Svezia 1.642
TR - Turchia 1.126
DE - Germania 1.030
FI - Finlandia 881
RU - Federazione Russa 806
IE - Irlanda 591
BR - Brasile 458
FR - Francia 302
VN - Vietnam 288
NL - Olanda 189
CA - Canada 178
IN - India 156
JP - Giappone 116
BE - Belgio 114
PL - Polonia 98
EU - Europa 80
AT - Austria 60
KR - Corea 55
ES - Italia 53
AR - Argentina 51
HK - Hong Kong 44
RO - Romania 42
BD - Bangladesh 36
KE - Kenya 32
AU - Australia 27
MX - Messico 26
CH - Svizzera 24
ID - Indonesia 23
ZA - Sudafrica 23
IQ - Iraq 21
LT - Lituania 18
IR - Iran 17
CL - Cile 16
SA - Arabia Saudita 16
TG - Togo 16
PK - Pakistan 14
AL - Albania 13
CO - Colombia 13
EC - Ecuador 13
MA - Marocco 11
PE - Perù 10
EE - Estonia 9
HU - Ungheria 9
GR - Grecia 8
IL - Israele 8
PY - Paraguay 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
DK - Danimarca 7
NZ - Nuova Zelanda 7
KG - Kirghizistan 6
LA - Repubblica Popolare Democratica del Laos 6
PH - Filippine 6
PT - Portogallo 6
UZ - Uzbekistan 6
AM - Armenia 5
AZ - Azerbaigian 5
BG - Bulgaria 5
EG - Egitto 5
HR - Croazia 5
JM - Giamaica 5
LU - Lussemburgo 5
SM - San Marino 5
UY - Uruguay 5
BO - Bolivia 4
CZ - Repubblica Ceca 4
KZ - Kazakistan 4
NP - Nepal 4
RS - Serbia 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
ET - Etiopia 3
HN - Honduras 3
IS - Islanda 3
JO - Giordania 3
LB - Libano 3
LV - Lettonia 3
MD - Moldavia 3
NO - Norvegia 3
BB - Barbados 2
BZ - Belize 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
FK - Isole Falkland (Malvinas) 2
IM - Isola di Man 2
KW - Kuwait 2
LK - Sri Lanka 2
MY - Malesia 2
OM - Oman 2
PA - Panama 2
Totale 54.680
Città #
Southend 5.676
Dallas 4.177
Woodbridge 3.099
Ann Arbor 2.232
Jacksonville 2.211
Houston 2.124
Chandler 1.869
Fairfield 1.852
Ashburn 1.672
Nanjing 1.223
Singapore 947
Cambridge 895
Izmir 876
Wilmington 826
Seattle 714
Beijing 709
Dublin 533
Boardman 492
Nanchang 465
San Mateo 345
Helsinki 320
Princeton 317
New York 273
Düsseldorf 255
Hebei 249
Shenyang 242
Tianjin 220
Changsha 199
Los Angeles 196
Jiaxing 186
Kunming 162
Moscow 158
Amsterdam 152
Istanbul 145
Munich 136
Des Moines 133
Velikiy Novgorod 125
Brussels 112
Shanghai 107
Santa Clara 97
Mülheim 93
Toronto 87
San Diego 85
Urbino 83
Bremen 81
Ho Chi Minh City 81
San Francisco 81
Jinan 78
Hangzhou 77
Council Bluffs 72
Guangzhou 72
Buffalo 71
Milan 69
London 61
Orciano Di Pesaro 61
Hanoi 60
Lanzhou 59
Zhengzhou 58
Changchun 57
Venice 57
Dong Ket 54
Ningbo 53
Nuremberg 49
Menlo Park 48
Warsaw 48
São Paulo 47
Seongnam 45
Frankfurt am Main 44
Vienna 42
Dearborn 41
Stockholm 41
Kraków 40
Chicago 39
Rome 38
Turku 38
Norwalk 37
Haikou 36
Montreal 35
Shenzhen 34
Tokyo 34
Brooklyn 32
Hong Kong 29
Taizhou 27
Secaucus 26
Wuppertal 26
Auburn Hills 25
Orem 25
Phoenix 25
Denver 24
Augusta 22
Fuzhou 22
Rio de Janeiro 22
Leawood 21
Parma 21
Ancona 20
Chennai 20
Redwood City 20
West Jordan 20
Atlanta 19
Hefei 19
Totale 39.472
Nome #
1-(2-Alkylamidoethyl)-6-methoxyindole Derivatives: A New Class of Potent Indole Melatonin Analogues. 1.283
1-Aminocyclopropane-1-carboxylic acid derivatives as ligands at the glicine-site of the NMDA receptor. 1.278
1,5-BENZODIAZEPINE-2,4-DIONE GASTRIN AND CHOLECYSTOKININ-B-RECEPTOR ANTAGONISTS 1.253
1,7-DIHYDROPYRROLO[3,4-e][1,4]DIAZEPIN-2(3H)-ONE DERIVATIVES, AND THEIR USE AS ANTICONVULSANT AND ANTIANXIETY AGENTS 1.247
Inibitori dell’enzima NAAA (N-Acylethanolamine-Hydrolizing Acid Amidase) come nuovi agenti antinfiammatori 836
1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID DERIVATIVES AS LIGANDS AT THE GLYCINE-BINDING SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR 413
Scoperta del primo inibitore dell’enzima idrolasi delle ammidi degli acidi grassi (FAAH) ad azione periferica 328
Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties 278
Divergent synthesis of novel 9-deazaxanthine derivatives via late-stage cross-coupling reactions 276
ORGANIC REACTIONS OF FLUOROXY COMPOUNDS: ADDITION REACTIONS OF UNACTIVATED AND DEACTIVATED UNSATURATED LINKAGES OF STEROIDS 274
Antidepressant-like Activity of the Fatty Acid Amide Hydrolase Inhibitor URB597 in a Rat Model of Chronic Mild Stress 266
A Second Generation of Carbamate-Based Fatty Acid Amide Hydrolase Inhibitors with Improved Activity in vivo 265
2-n-Butyl- 9-methyl-8-(1,2,3)triazol-2-yl-9H-purin-6-ylamine and Analogues as A2A Adenosine Receptor Antagonists. Design, Synthesis, and Pharmacological Characterization 263
ENOLATES OF 17,20:20,21-BISMETHYLENEDIOXYPREDNISONE 260
A new melatonin receptor ligand with mt1-agonist and MT2-antagonist properties 260
Potent, Metabolically Stable 2-Alkyl-8-(2H-1,2,3-triazol-2-yl)-9H-adenines as Adenosine A2A Receptor Ligands 259
(E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists. 257
3-(2-Carbamoylvinyl)-4,5-dimethylpyrrole-2-carboxylic acids as ligands at the NMDA glycine-binding site: a study on the 2-carbamoylvinyl chain modification 257
Structure–Property Relationships of a Class of Carbamate-Based Fatty Acid Amide Hydrolase (FAAH) Inhibitors: Chemical and Biological Stability 255
Tricyclic Alkylamides as Melatonin Receptor Ligands with Antagonist or Inverse Agonist Activity 254
Alkyl 2 (Diphenyl-methyleneamino) acrylates in the Synthesis of α-Amino Acids 252
Sintesi e studi di relazione struttura-attività/stabilità di carbammati inibitori dell’enzima FAAH 252
Synthesis of benzo[1,2-d;3,4-d’]diimidazole and 1H-pyrazolo[4,3-b]pyridine as putative A2A receptor antagonists 250
4,5-Dihydroisoxazole and 4,5-dihydro-1,2,4-oxadiazole derivatives from cycloaddition reactions of nitrile oxides to alkyl N-(diphenylmethylene)-α ,β -dehydroamino acids 247
An improved route to cycloalka[b]pyrrole 2-carboxylates 240
Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: Steric effects of N-alkyl chain on rat plasma and liver stability 240
Synthesis and Biological Evaluation of Metabolites of 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535), A Potent Antagonist of the A2AAdenosine Receptor for the Treatment of Parkinson’s Disease 237
5-(2-Ethyl-phenyl)-3-(3-methoxy-phenyl)-1H-[1,2,4]triazole (DL-111-IT ) and related compounds induce morphological apoptotic patterns in cultures of human tumor cell lines 236
Synthesis and Biological Activity of new melatonin dimeric derivatives. 235
10-(1-HYDROXYMETHYL)-11-OXO-1-AZATRICYCLOUNDEC-2-ENE-2-CARBOXYLIC ACID ESTERS USEFUL AS ANTIBACTERIAL AND PROCESS FOR THEIR PREPARATION 235
Identification of a Bioactive Impurity in a Commercial Sample of 6-Methyl-2-p-tolylaminobenzo[d][1,3]oxazin-4-one (URB754) 235
"Hot spots" in Medicinal Chemistry 234
Reassessing the melatonin pharmacophore: enantiomeric resolution, pharmacological activity, structure analysis, and molecular modeling of a constrained chiral melatonin analogue. 234
2,4,5-TRISUBSTITUTED OXAZOLES 232
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis 228
POSITIVE ION-MASS SPECTRA AND COLLISION-INDUCED DISSOCIATION OF SOME 2,3-DIDEHYDRO AMINO ACIDS 223
2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists 222
Modulation of Anxiety Through Blockade of Anandamide Hydrolysis 221
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation 221
SULLA MICELIANAMMIDE 220
N (Diphenylmethylene)-α,β−didehydroamino Acid Esters. Thermal and Lewis Acid Induced Dimerizations 220
Application of a non-electrophysiological method to study binding affinity and efficacy of glicine analogs to the glicine site of the NMDA receptor-ion channel complex. 216
Cyclohexylcarbamic Acid 3’-or 4’-Substituted Biphenyl-3-yl Esters as Fatty Acid Amide Hydrolase Inhibitors: Synthesis Quantitative Structure–Activity Relationships, and Molecular Modeling Studies 216
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 214
2,3-Dehydroamino acid derivatives as intermediates in the synthesis of heterocyclic compounds. 213
Toward the Definition of Stereochemical Requirements for MT(2)-Selective Antagonists and Partial Agonists by Studying 4-Phenyl-2-propionamidotetralin Derivatives 210
5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors, preparation, and therapeutic use.. 209
N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands. 209
TEICOPLANIN HYDRAZIDES AS ANTIBACTERIALS 207
An endocannabinoid mechanism for stress-induced analgesia 206
Mechanisms of action and antiproliferative properties of URB631 in human breast cancer 205
Synthesis and Structure–Activity Relationships of a Series of Pyrrole Cannabinoid Receptor Agonists 204
3,6-DISUBSTITUTED TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES 204
Bivalent Ligand Approach on N-[2-[(3-methoxyphenyl)methylamino]ethyl]acetamide. Synthesis, Binding Affinity and Intrinsic Acivity for MT(1) and MT(2) melatonin Receptors. 204
Anandamide suppressess pain initiation through a peripheral endocannabinoid mechanism 204
Differentiation between isomeric 1-aminocyclopropane-1-carboxylic acid derivatives by means of chemical ionisation and mass selected collision induced dissociation 203
(E)-3-[2-(Carbamoylvinyl)]pyrrol-2-carboxylic acid derivatives: A novel Class of glycine site Antagonists. 201
Plant-derived phenolic compounds prevent the DNA single-strand breakage and cytotoxicity induced by tert-butylhydroperoxide via an iron-chelating mechanism. 201
Synthesis and Structure–Activity Relationship (SAR) of 2-Methyl-4-oxo-3-oxetanyl Carbamic Acid Esters, a Class of Potent N-Acylethanolamine Acid Amidase (NAAA) Inhibitors 199
X-RAY STRUCTURE DETERMINATION OF MEXIPROSTIL, A NEW GASTROPROTECTIVE 16-METHOXY-16METHYL-PGE1 ANALOGUE 198
2,4-Dicarboxy-pyrroles as Selective Non-Competitive mGluR1 Antagonists: an exploration of the role of the pyrrolic scaffold 198
O-Biphenyl-3-yl Carbamates as Peripheral FAAH Inhibitors: Synthesis and Structure–Activity (SAR) Relationship Studies 198
Conformationally Restrained Melatonin Analogs: Synthesis, Binding Affinity for the Melatonin Receptor, Evaluation of the Biological Activity, and Molecular Modeling Study 197
Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand 197
Peripherally Restricted FAAH Inhibitors 197
Design and synthesis of N-[3,3-diphenyl-propenyl]alkanamides as a novel class of potent MT2-selective Melatonin receptor ligands 196
N-(Substituted-anilinoethyl)acylamides: Design, Synthesis and Pharmacological Characterization of a New Class of Melatonin Receptor Ligands 196
2,3-Dihydro-6,7-dichloro-pyrido[2,3-b]pyrazine-8-oxide as Selective Glycine Antagonist with in vivo Activity. 196
N-(DIPHENYLMETHYLENE)-ALPHA,BETA-DIDEHYDROAMINO ACID ESTERS. THERMAL AND LEWIS ACID INDUCED DIMERIZATIONS 195
Synthesis, Enantiomeric Resolution and Structure-Activity Relationship Study for a Series of 10,11-Dihydro-5H-dibenzo[a,d]cycloheptene MT2 Receptor Antagonists. 195
Synthesis of (E)-8-(3-Chlorostyryl)caffeine Analogues Leading to 9-Deazaxanthine Derivatives as Dual A2AAntagonists/MAO-B Inhibitors 195
N-acetiltriptamine 2,5-sostituite: sintesi e valutazione dell’attività biologica per i recettori melatoninergici MT1 e MT2 194
Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models 194
Synthesis and Quantitative Structure–Activity Relationship of Fatty Acid Amide Hydrolase Inhibitors: Modulation at the N-Portion of Biphenyl-3-yl Alkylcarbamates 193
N-Acyl-5- and -2,5-substituted tryptamines: synthesis, activity and affinity for human mt1 and MT2 melatonin receptors 192
Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them dual substrates for Abcb1 and Abcg2 and restrict their access to the brain 191
SYNTHESIS, BINDING AFFINITY FOR THE MELATONIN RECEPTOR, AND EVALUATION OF THE BIOLOGICAL ACTIVITY OF NEW INDOLE-BASED MELATONIN ANALOGUES. 191
2-N-Acylaminoalkylindoles: Design and Quantitative Structure-Activity Relationship Studies Leading to MT2-Selective Antagonists. 190
(2-AMINOETHYL)IMIDAZOLES.SYNTHESIS OF 1,4-DIMETHYL-5-PHENYL-2-[2-(4-PHENYLPIPERAZINYL)ETHYL]IMIDAZOLE 190
GENERALISED ELECTROPHILIC FLUORINATION BY FLUOROXY COMPOUNDS 189
Design, Synthesis and Structure–Activity Relationships of Alkylcarbamic Acid Aryl Esters, a New Class of Fatty Acid Amide Hydrolase Inhibitors 189
MELATONIN RECEPTOR AGONISTS: SAR AND APPLICATIONS TO THE TREATMENT OF SLEEP-WAKE DISORDERS 187
Alchilammidi tricicliche: legandi selettivi dei recettori melatoninergici MT1 e MT2 186
The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3’-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice 186
Sintesi e studi biologici preliminari su analoghi di URB937, il primo inibitore ad azione periferica dell'enzima FAAH 185
SYNTHESIS AND BIOLOGICAL PROPERTIES OF N63-CARBOXAMIDES OF TEICOPLANIN ANTIBIOTICS. STRUCTURE-ACTIVITY RELATIONSHIPS. 184
UNIVERSITY EDUCATION OF MEDICINAL CHEMISTS: COMPARISON OF EIGHT COUNTRIES 183
SUITABILITY OF FAST-ION BOMBARDMENT MASS SPECTROMETRY FOR THE INVESTIGATION OF 11,4-DIHYDROPYRIDINE DERIVATIVES 183
Application of 3D-QSAR in the Rational Design of Receptor Ligands and Enzyme Inhibitors 183
ANGIOTENSIN CONVERTING ENZYME INHIBITORS AS ANTIHYPERTENSIVE AGENTS: 1-[´2-MERCAPTOCYCLOALKYL`CARBONYL]-L-PROLINES 182
2 - Arachidonoylglycerol and anandamide are endocannabinoid mediators of stress - induced analgesia 182
URB602 Inhibits Monoacylglycerol Lipase and Selectively Blocks 2-Arachidonoylglycerol Degradation in Intact Brain Slices 181
Modulation of anxiety through blockade of anandamide hydrolysis 181
Melatonin prevents apoptosis induced by UV-B treatment in U937 cell line. 180
Synthesis and Structure–Activity Relationships of FAAH Inhibitors: Cyclohexylcarbamic Acid Biphenyl Esters with Chemical Modulation at the Proximal Phenyl Ring 180
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus 178
6-(ALKYLAMINO)-3-ARYL-1,2,4-TRIAZOLO[3,4-A]PHTHALAZINES. A NEW CLASS OF BENZODIAZEPINE RECEPTOR LIGANDS 178
2-(1,1'-BIPHEN-4-YL)-1,2,4-TRIAZOLE[5,1-a]ISOQUINOLINE (L-14105), A POTENTIAL ORALLY ACTIVE CONTRAGESTATIONAL AGENT FOR THE BITCH: STUDIES IN THE RAT, HAMSTER AND DOG 177
Metastable ion studies in the characterization melatonin isomers 177
DEAMINOTEICOPLANIN AND ITS DERIVATIVES. SYNTHESIS, ANTIBACTERIAL ACTIVITY, AND BINDING STRENGTH TO Ac-D-ALA-D-ALA 176
Totale 26.421
Categoria #
all - tutte 175.185
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 175.185


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.193 0 0 0 0 0 371 263 371 700 425 743 320
2021/20223.235 188 375 398 514 74 84 111 202 219 136 41 893
2022/20235.271 613 291 153 643 460 1.157 15 428 868 137 354 152
2023/20241.271 165 132 78 157 81 294 65 80 19 88 22 90
2024/20254.519 285 248 1.123 275 98 424 452 305 369 254 376 310
2025/20268.993 769 2.014 3.712 1.659 789 50 0 0 0 0 0 0
Totale 54.987